Cargando…
Chemokines in Alzheimer’s Disease: New Insights Into Prokineticins, Chemokine-Like Proteins
Alzheimer’s disease is the most common neurodegenerative disorder characterized by the presence of β-amyloid aggregates deposited as senile plaques and by the presence of neurofibrillary tangles of tau protein. To date, there is a broad consensus on the idea that neuroinflammation is one of the most...
Autores principales: | Zuena, Anna Rita, Casolini, Paola, Lattanzi, Roberta, Maftei, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6568308/ https://www.ncbi.nlm.nih.gov/pubmed/31231219 http://dx.doi.org/10.3389/fphar.2019.00622 |
Ejemplares similares
-
Involvement of the Chemokine Prokineticin-2 (PROK2) in Alzheimer’s Disease: From Animal Models to the Human Pathology
por: Lattanzi, Roberta, et al.
Publicado: (2019) -
The Role of Prokineticin 2 in Oxidative Stress and in Neuropathological Processes
por: Lattanzi, Roberta, et al.
Publicado: (2021) -
Multimodal antidepressant vortioxetine causes analgesia in a mouse model of chronic neuropathic pain
por: Zuena, Anna Rita, et al.
Publicado: (2018) -
Identification and Characterization of a New Splicing Variant of Prokineticin 2
por: Lattanzi, Roberta, et al.
Publicado: (2022) -
Potential Clinical Role of Prokineticin 2 (PK2) in Neurodegenerative Diseases
por: Maftei, Daniela, et al.
Publicado: (2022)